Clinical Study of "Eclar Ointment" (Deprodone Propionate) on Eczema and Dermatitis in Childhood.

DOI

Bibliographic Information

Other Title
  • 小児湿疹・皮膚炎群に対するエクラー軟膏の有効性および安全性の検討

Description

To confirm the efficacy, safety and usefulness of Eclar® ointment and cream in childhood, a post-marketing clinical study was investigated. Eclar® ointment and cream contain 0.3% deprodone propionate as synthesized adrenal corticoid hormone. Eclar® ointment and cream were topically applied to the following 56 patients of children 40 exudative dermatitis (36 patients on ointment and 4 patients on cream) and 16 lichenified dermatitis (13 patients on ointment and 3 patients on cream). The rate of efficacy on 49 cases treated with ointment was 87.8% as overall evaluated “improved”, and 100.0% as overall evaluated “slightly improved”. The number of cases treated with cream were too few (7 cases) to be evaluated for analysis of efficacy. From these results, it is estimated that Eclar® ointment is effective, safe and useful as topical treatment on eczema and dermatitis in childhood.

Journal

  • Skin research

    Skin research 35 (6), 743-754, 1993

    Meeting of Osaka Dermatological Association

Keywords

Details 詳細情報について

  • CRID
    1390282679775233792
  • NII Article ID
    130004045570
  • DOI
    10.11340/skinresearch1959.35.743
  • ISSN
    1884541X
    00181390
  • Text Lang
    ja
  • Data Source
    • JaLC
    • CiNii Articles
  • Abstract License Flag
    Disallowed

Report a problem

Back to top